Insight

Triantafyllos Stylianopoulos: The role of the mast cells in reprogramming the tumor micro-environment

Photo from Triantafyllos Stylianopoulos/LinkedIn

Apr 9, 2024, 13:03

Triantafyllos Stylianopoulos: The role of the mast cells in reprogramming the tumor micro-environment

Triantafyllos Stylianopoulos, Associate Professor at the University of Cyprus, Head of Cancer Biophysics Lab, made the following post on LinkedIn:

”Our new article in AACR Journals Clinical Cancer Research for the role of the mast cells in reprogramming the tumor micro-environment! Stabilizing their function with the anti-histamine ketotifen can improve immunotherapy in sarcomas. Early data from our ongoing clinical trial of ketotifen are presented!
This research was supported by the European Research Council (ERC).”

Read further.
Source: Triantafyllos Stylianopoulos/LinkedIn

AACR Journals Clinical Cancer Research cancer Cancer Biophysics Lab clinical trial ERC European Research Council immunotherapy ketotifen OncoDaily Oncology sarcoma Triantafyllos Stylianopoulos tumor micro-environment University of Cyprus

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage